Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Revenue (2016 - 2025)

Historic Revenue for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to $18025.0.

  • Silo Pharma's Revenue changed 0.0% to $18025.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $72102.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $72102.0 for FY2024, which is 0.0% changed from last year.
  • Silo Pharma's Revenue amounted to $18025.0 in Q3 2025, which was down 0.0% from $18025.0 recorded in Q2 2025.
  • Silo Pharma's 5-year Revenue high stood at $86148.0 for Q1 2022, and its period low was -$483.0 during Q3 2021.
  • In the last 5 years, Silo Pharma's Revenue had a median value of $18025.0 in 2022 and averaged $23861.8.
  • Over the last 5 years, Silo Pharma's Revenue had its largest YoY gain of 1603367.35% in 2021, and its largest YoY loss of 10296.59% in 2021.
  • Silo Pharma's Revenue (Quarter) stood at -$164.0 in 2021, then soared by 11091.46% to $18026.0 in 2022, then changed by 0.0% to $18026.0 in 2023, then changed by 0.0% to $18026.0 in 2024, then decreased by 0.01% to $18025.0 in 2025.
  • Its last three reported values are $18025.0 in Q3 2025, $18025.0 for Q2 2025, and $18026.0 during Q1 2025.